This
provides more flexibility than the current registered
savings plans for which tax is applicable on withdrawals.
Lucentis
will be added to the provincial drug formulary this
month. Lucentis is a prescription medicine developed
for the treatment of patients with wet age-related
macular degeneration (AMD). It is administered as
an injection into the eye by a physician. It contains
agents designed to block growth of abnormal blood
vessels that can leak blood and other fluids. Clinical
research has shown that Lucentis not only stops vision
deterioration associated with AMD, but improves visual
capacity in 40% of cases.
I
understand you require nine needles the first year
at approximately $1600 each and six needles the second
year. Please don't get your hopes up too high as I
understand there are a lot of stipulations before
you receive the treatment. Check with your doctor
to find out the requirements to receive these needles.
Did
you know drivers 50 - 65 lead the pack for vehicle
maintenance?
Survey
findings: